Expression of JAKs/STATs pathway molecules in rat model of rapid focal segmental glomerulosclerosis

Pediatric Nephrology

Volumn 24, Issue 9, 2009, Pages 1661-1671

  Liang, Yaojun ^a   Jin, Yu ^a   Li, Yuning ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Focal segmental glomerulosclerosis; JAK2; JAKs STATs signaling; PIAS1,3; SOCS1,3; STAT1,3; TGF 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 4; CREATININE; JANUS KINASE 1; JANUS KINASE 2; STAT1 PROTEIN; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 2; TRANSFORMING GROWTH FACTOR BETA1; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE COURSE; ENZYME PHOSPHORYLATION; FOCAL GLOMERULOSCLEROSIS; GENE ACTIVATION; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; GENE TARGETING; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING;

ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; DOXORUBICIN; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION; GENETIC MARKERS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; JANUS KINASES; KIDNEY; KIDNEY FUNCTION TESTS; MALE; NEPHRECTOMY; PROTEIN INHIBITORS OF ACTIVATED STAT; RATS; RATS, WISTAR; RNA, MESSENGER; SIGNAL TRANSDUCTION; SPECIFIC PATHOGEN-FREE ORGANISMS; STAT TRANSCRIPTION FACTORS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 68449095554     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-009-1163-4     Document Type: Article

References (33)

1. Cattran DC, Rao P (1998) Long-term outcome in children and adults with classic focal segmental glomerulosclerosis. Am J Kidney Dis 32:72-79
2. Boyer O, Moulder JK, Somers MJ (2007) Focal and segmental glomerulosclerosis in children: A longitudinal assessment. Pediatr Nephrol 22:1159-1166
3. Hogg R, Middleton J, Vehaskari VM (2007) Focal segmental glomerulosclerosis-epidemiology aspects in children and adults. Pediatr Nephrol 22:183-186
4. Ichikawa I, Fogo A (1996) Focal segmental glomerulosclerosis. Pediatr Nephrol 10:374-391
5. Shiiki H, Dohi K (2000) Primary focal segmental glomerulosclerosis: clinical course, predictors of renal outcome and treatment. Intern Med 39:606-611
6. Schlondorff D, Nelson PJ, Luckow B, Banas B (1997) Chemokines and renal disease. Kidney Int 51:610-621
7. Brabcova I, Kotsch K, Hribova P, Louzecká A, Bartosová K, Hyklová K, Lácha J, Volk HD, Viklický O (2007) Intrarenal gene expression of proinflammatory chemokines and cytokines in chronic proteinuric glomerulopathies. Physiol Res 56:221-226
8. Mezzano SA, Droguett MA, Burgos ME, Ardiles LG, Aros CA, Caorsi I, Egido J (2000) Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy. Kidney Int 57:147-158
9. Chatterjee-Kishore M, van den Akker F, Stark GR (2000) Association of STATs with relatives and friends. Trends Cell Biol 10:106-111
10. Leaman DW, Leung S, Li X, Stark GI (1996) Regulation of STAT-dependent pathways by growth factors and cytokines. FASEB J 10:1578-1588
11. Chung CD, Liao J, Liu B, Rao X, Jay P, Berta P, Shuai K (1997) Specific inhibition of Stat3 signal transduction by PIAS3. Science 278:1803-1805
12. Liu B, Liao J, Rao X, Kushner SA, Chung CD, Chang DD, Shuai K (1998) Inhibition of Stat1-mediated gene activation by PIAS1. Proc Natl Acad Sci USA 95:10626-10631
13. Shuai K (2006) Regulation of cytokine signaling pathways by PIAS proteins. Cell Res 16:196-202
14. Wormald S, Hilton DJ (2004) Inhibitors of cytokine signal transduction. J Biol Chem 279:821-824
15. Tan JC, Rabkin R (2005) Suppressors of cytokine signaling in health and disease. Pediatr Nephrol 20:567-575
16. Cooney RN (2002) Suppressors of cytokine signaling (SOCS): Inhibitors of the JAK/STAT pathway. Shock 17:83-90
17. Kile BT, Alexander WS (2001) The suppressors of cytokine signalling (SOCS). Cell Mol Life Sci 58:1627-1635
18. Marrero MB, Banes-Berceli AK, Stern DM, Stern DM, Eaton DC (2006) Role of the JAK/STAT signaling pathway in diabetic nephropathy. Am J Physiol 290:F762-F768
19. Martinez-Lostao L, Ordi-Ros J, Balada E, Segarra-Medrano A, Majó-Masferrer J, Labrador-Horrillo M, Vilardell-Tarre7acute;s M (2007) Activation of the signal transducer and activator of transcription-1 in diffuse proliferative lupus nephritis. Lupus 16:483-488
20. Li R, Yang N, Zhang L, Huang Y, Zhang R, Wang F, Luo M, Liang Y, Yu X (2007) Inhibition of Jak/STAT signaling ameliorates mice experimental nephrotic syndrome. Am J Nephrol 27:580-589
21. Shi YH, Zhao S, Wang C, Li Y, Duan HJ (2007) Fluvastatin inhibits activation of JAK and STAT proteins in diabetic rat glomeruli and mesangial cells under high glucose conditions. Acta Pharmacol Sin 28:1938-1946
22. Grond J, Weening JJ, van Goor H, Elema JD (1988) Application of puromycin aminonucleoside and adriamycin to induce chronic renal failure in the rat. Contrib Nephrol 60:83-93
23. Okuda S, Oh Y, Tsuruda H, Onoyama K, Fujimi S, Fujishima M (1986) Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease. Kidney Int 29:502-510
24. Raij L, Azar S, Keane W (1984) Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 26:137-143
25. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408
26. Shankland SJ (2006) The podocyte's response to injury: Role in proteinuria and glomerulosclerosis. Kidney Int 69:2131-2147
27. Kim HS, Lee MS (2007) STAT1 as a key modulator of cell death. Cell Signal 19:454-465
28. Bromberg JF (2001) Activation of STAT proteins and growth control. Bioessays 23:161-169
29. Battle TE, Frank DA (2002) The role of STATs in apoptosis. Curr Mol Med 2:381-392
30. Eddy AA (1994) Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. J Am Soc Nephrol 5:1273-1287
31. Ivashkiv LB (2000) Jak-STAT signaling pathways in cells of the immune system. Rev Immunogenet 2:220-230
32. Mu W, Ouyang X, Agarwal A, Zhang L, Long DA, Cruz PE, Roncal CA, Glushakova OY, Chiodo VA, Atkinson MA, Hauswirth WW, Flotte TR, Rodriguez-Iturbe B, Johnson RJ (2005) IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease. J Am Soc Nephrol 16:3651-3660
33. Alexander WS (2002) Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev 2:410-416